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The proteins secreted by a particular type of cell, the secretome, play important roles in
the regulation of many physiological processes via paracrine/autocrine mechanisms, and
they are of increasing interest to help understanding rare diseases and to identify potential
biomarkers and therapeutic targets. To facilitate ongoing research involving secreted
proteins, we revisited cell culture protocols and whole secreted protein enrichment
protocols. A reliable method for culturing and precipitating secreted protein from
patient-derived fibroblast conditioned-mediumwas established. The method is based on
the optimization of cell confluency and incubation time conditions. The well-established
carrier-based TCA-DOC protein precipitation method was consistently found to give
higher protein recovery yield. According to our results, we therefore propose that
protein enrichment should be performed by TCA-DOC precipitation method after 48 h
at 95% of confluence in a serum-deprived culture medium. Given the importance of
secreted proteins as a source to elucidate the pathogenesis of rare diseases, especially
neurological disorders, this approach may help to discover novel candidate biomarkers
with potential clinical significance.
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INTRODUCTION
The secretome, a complex set of molecules secreted from living cells, represents a major class of
proteins. It is considered to be encoded by ∼10% of the human genome (Pavlou and Diamandis,
2010). It is well known that secreted proteins are associated with a broad range of physiological
processes and play a key role in homeostasis, growth, differentiation, proteolysis, apoptosis,
signaling, cell adhesion, and development of the extracellular matrix (ECM; Luo et al., 2012; Stastna
and Van Eyk, 2012). Furthermore, the proteins secreted by particular types of cells are of increasing
interest as a potential source of biomarker discoveries and therapeutic targets in diseases. Although
the proteins released by cells into conditioned-media in vitro have been studied abundantly to better
understand pathological conditions and mechanisms, the concept of the secretome has become an
attractive and challenging proteomic technology in recent years.
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There has been an increasing number of studies over the
last decade targeting the secretome characterization, spanning
a wide range of biological samples from microorganisms and
lower animal models to human embryos and cell lines leading
to the generation of a valuable secretome catalogs (Leroy et
al., 2006; Klee, 2008; Katz-Jaffe et al., 2009; Brown et al.,
2013; Gelman et al., 2013; Hartwig et al., 2013; Makridakis
et al., 2013; Meissner et al., 2013). These efforts have been
greatly facilitated by significant technological advances in the
field of proteomics during the last two decades [improvement
of proteomic platforms, mass spectrometry instrumentation
and 2D-difference gel electrophoresis (2D-DIGE); Klose, 1975;
O’Farrell, 1975; Beckett, 2012; Mukherjee and Mani, 2013].
The 2D-GE technique, introduced in 1976, enables protein
separation according to their isoelectric point (pI) and molecular
weight (Bensadoun and Weinstein, 1976; Peterson, 1977; Feist
and Hummon, 2015). The 2D-DIGE technique addresses the
problems encountered in the 2D-GE technique, which were a
lack of reproducibility and quantification, and was introduced by
Unlü et al. (Unlü et al., 1997). Using CyDyes (2, 3, and 5) for
protein labeling, which are fluorescent dyes, the samples can be
pooled and separated on one single 2D-PAGE (polyacrylamide
gel electrophoresis) gel and then scanned by detecting each
CyDye independently. The spots observed can be analyzed for
expression levels and extracted from the gels for further analysis
by mass spectrometry. The direct advantages of this technique
is the use of an internal standard, generally a protein pool
conjugated with the Cy2 fluorescent dye, and the multiplexing of
the samples implying the simultaneous measurement of multiple
analytes in a single analytical run and therefore increasing the
power for statistical analysis (Minden, 2007). Along these lines,
there has been a growing effort over the last few years to analyze
fibroblast secretomes by proteomic approaches (secretomics),
to allow the identification of molecules secreted by fibroblast
cells and consequently gain insight into the mechanisms of
immunomodulation, inflammation, angiogenesis, cell survival,
or cell differentiation and recruitment in various health and
diseases or conditions. Despite these advances, secretome
analysis still faces some difficulties mainly related to sample
collection and preparation.
The secretome is a challenging sample to analyze, mainly due
to inherent difficulties with sample collection and preparation
since secreted proteins are quite diluted and often present
in µg to ηg. In addition, culture media often contains
salts and other compounds such as phospholipids, lipids
and polysaccharides, which interfere with most proteomics
techniques. Thus, selective carrier-based precipitation of proteins
becomes almost mandatory for proper subsequent secretomic
analysis (Chevallet et al., 2007). Therefore, since the analysis
of secreted proteins is challenging due to technical difficulties
related to cell collection and preparation, the principal aim of
this study was to determine the optimal time to harvest fibroblast
conditioned-media and the best protein precipitation and
conjugation methods for the subsequent secretomic screening
experiments. A variety of methods have been previously
described to extract diluted secreted proteins usually present
in conditioned culture media in low concentration. These
techniques present several drawbacks, such as coprecipitation
of salts or poor yields at low protein concentrations. Samples
should have a high protein concentration and be free of salt and
other disturbing factors, such as ionic detergents, nucleic acids,
and lipids that could interfere with downstream analysis. Protein
concentration methods, such as absorption to hydrophobic resin,
ultrafiltration, lyophilisation, and dialysis, are therefore not
ideal for subsequent secrotomic analysis. From the data already
present in the literature, we ruled out two carrier-based protein
precipitation methods proven to be highly efficient to recover
diluted proteins from culture media, trichloroacetic—sodium
deoxycholate (TCA-DOC) and tetrahydrofuran—sodium lauroyl
sarcosinate (TCA-NLS-THF) (Bensadoun and Weinstein, 1976;
Chevallet et al., 2007; Feist and Hummon, 2015). In the
current work, we found that the TCA precipitation protocol
we described, enabling protein precipitation from large sample
volumes, gave high yield protein recovery.
MATERIALS AND METHODS
Sample Selection and Collection
All cases signed a consent form approved by our Institutional
Ethics Committees prior to being enrolled in the study and were
recruited on a voluntary basis (Ethical research board of the CHU
de Québec. Protocol number: 2012-1316. For more information,
please contact gurecherche@chuq.qc.ca). Skin biopsies were
collected from affected and unaffected individuals. Two different
pathologies and control individuals were targeted in order to
fully validate our results. Besides collecting skin biopsies, blood
samples were also collected and used for DNA extraction and
patient’s genotyping to confirm diagnosis when possible. In total,
6 Amyotrophic Lateral Sclerosis (ALS), 3 neurofibromatosis type
1 (NF1) cases, and 3 controls individuals were recruited for this
study (Table 1). Fibroblasts were used in this study as they are
known to be affected in different neurological conditions as ALS
and NF1 (De Schepper et al., 2005; Maertens et al., 2007; Paré et
al., 2015; García-Romero et al., 2016).
Skin Biopsies and Fibroblast Cell
Extraction/Culture
For each participant, two skin biopsies were collected using a
6-mm diameter punch biopsy. All skin biopsies were taken from
the same body area for each subject and fibroblasts were isolated
as described before (Paré et al., 2015). Briefly, the skin biopsies
were incubated with 0.05% thermolysin (Sigma, Oakville, QC,
Canada), overnight at 4◦C, in order to facilitate the mechanical
separation of the epidermis from the dermis. Then, fibroblasts
were isolated from the dermis after treatment with 0.2 IU/ml
collagenase H (Roche, Missisauga, Ontario, Canada). Cultured
fibroblasts, grown in DMEM (Dulbecco-Vogt modification
of Eagle’s medium; Invitrogen, Burlington, ON, Canada)
supplemented with 10% Bovine Growth Serum (HyClone BGS;
GE Healthcare Life Sciences, HyClone Laboratories, Logan, UT,
USA), 100 IU/ml penicillin G (Sigma, Oakville, QC, Canada), and
25 µg/ml gentamicin (Schering, Pointe-Claire, QC, Canada) in
5% CO2 at 37
◦C, at passage two were seeded at a concentration
of 2.5× 105 cells on tissue culture dishes (75 cm2).
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TABLE 1 | Detailed clinical information of patients and controls enrolled in this study.
ID number Biopsy location Sex Age at sampling Current age Age of death Clinical status Genetic status
SALS 1 Arm M 48 NA NA Affected No known ALS-associated mutations
SALS 2 Arm M 62 NA NA Affected No known ALS-associated mutations
SALS 3 Arm M 81 NA NA Affected No known ALS-associated mutations
FALS1 Arm F 63 65 NA Clinically unaffected C9orf72 expansion
FALS2 Arm F 47 49 NA Clinically unaffected C9orf72 expansion
FALS3 Arm F 59 60 NA Affected C9orf72 expansion
NFM1 Arm M 25 26 NA Affected NA
NFM2 Arm M 26 27 NA Affected NA
NFM3 Arm F 22 23 NA Affected NA
CTRL 1 Arm F 68 69 NA Control NA
CTRL 2 Arm M 23 39 NA Control NA
CTRL 3 Arm M 29 45 NA Control NA
SALS, Sporadic ALS; FALS, Familial ALS; NFM, Neurofibromatosis type 1; CTRL, Control; M, Male; F, Female; NA, not applicable or info not available.
Fibroblast Induction and Protein
Precipitation
Secreted proteins are often masked by high amounts of
protein supplements in the culture medium. We have therefore
developed a serum-deprived efficient method for the enrichment
and analysis of the secretome of different fibroblast cell lines
to overcome this difficulty. After three washes with 10ml of
phosphate-buffered saline (PBS) [0.8% (W/V) NaCl (BioBasic
Inc., Markham, Ontario, Canada), 0.02% (W/V) KCl (BioBasic
Inc., Markham, Ontario, Canada), 0.15% (W/V) Na2HPO4
(BioBasic Inc., Markham, Ontario, Canada), 0.02% (W/V)
K2HPO4 (BioBasic Inc., Markham, Ontario, Canada)], the
fibroblasts were deprived of serum [DMEM (Dulbecco-Vogt
modification of Eagle’s medium) (Invitrogen, Burlington, ON,
Canada) supplemented with 100 IU/ml penicillin G (Sigma,
Oakville, QC, Canada) and 25 µg/ml gentamicin (Schering,
Pointe-Claire, QC, Canada) in 5% CO2 at 37
◦C]. This technique
has been previously shown to induce secretion of proteins
(Villarreal et al., 2013). Using this approach, previous work
also demonstrated that short serum deprivation periods did
not affect cellular viability from 48 h and inward (Del Galdo
et al., 2010; Villarreal et al., 2013; Rogers et al., 2014).
Fibroblast’s supernatants were therefore collected at different
confluence levels and at different collection times after serum
deprivation; 24 h pre-confluence, 48 h pre-confluence, 24 h
post-confluence, and 48-post confluence (please note that the
term pre-confluence is defined as a confluence of 40% and
post-confluence as a confluence of 95%). Four tissue culture
dishes (75 cm2) were seeded for each condition and all the
supernatants were collected. They were then centrifuged at 300 g
for 10min (4◦C) and kept at −80◦C until use. The proteins
present in the patient-derived fibroblast conditioned-media
were concentrated by the TCA-DOC and the TCA-NLS-THF
precipitation methods as described in the Supplementary Data.
The protein recovery yield for each culture condition was
assessed via a Bradford assay (BioBasic Inc., Markham, Ontario,
Canada).
TCA-DOC
The supernatants (40ml) were thawed on ice in high-speed
centrifuge tube. 1% (v/v) of a 2% sodium deoxycholate solution
(Fisher Scientific, Ottawa, Ontario, Canada) was added to each
tube and they were incubated on ice for 30min after mixing.
Trichloroacetic acid was then added to a final concentration
of 7.5% (v/v) (BioBasic Inc., Markham, Ontario, Canada) and
incubated again on ice for 60min after mixing. Proteins were
precipitated by centrifugation (15,000 g for 20min at 4◦C) and
the supernatants were discarded. Twenty milliliters of 100% ice-
cold (−20◦C) acetone (EMD, Darmstadt, Germany) were added
to the pellets, gently vortexed and kept at −20◦C for 5min.
After centrifugation (15,000 g for 5min at 4◦C), the supernatants
were discarded and 5ml of 100% ice-cold (−20◦C) acetone were
added to the pellets. The pellets were again gently vortexed, kept
at −20◦C for 5min, centrifuged (15,000 g for 5min at 4◦C),
and the supernatant discarded. The pellets were air-dried in a
chemical hood for 30min, dissolved in 210 µl of Isoelectric
Focusing (IEF) buffer, pH 8.5 [7M urea (BioBasic Inc., Markham,
Ontario, Canada), 2M thiourea (GE Healthcare, Little Chalfont,
Buckinghamshire, United Kingdom), 30mM TRIS (BioBasic
Inc., Markham, Ontario, Canada), and 4%CHAPS (BioBasic Inc.,
Markham, Ontario, Canada)], vortexed, centrifuged (15,000 g for
10min at room temperature), and kept at−80◦C until use.
TCA-NLS-THF
The supernatants (40ml) were thawed on ice in high-speed
centrifuge tubes. 1% (v/v) of a 2% sodium layroyl sarcosine
solution (Sigma-Aldrich, Oakville, Ontario, Canada) was added
to the tubes and they were incubated on ice for 30min after
mixing. Trichloroacetic acid was added to a final concentration
of 7.5% (v/v) (BioBasic Inc., Markham, Ontario, Canada) and
the supernatants were incubated on ice for 60min after mixing.
Proteins were precipitated by centrifugation (15,000 g for 20min
at 4◦C) and the supernatants were then discarded. 10% of the
initial volume of ice-cold (−20◦C) tetrahydrofuran (BioBasic
Inc., Markham, Ontario, Canada) was added, vortexed until
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complete dissolution of the pellets and kept at −20◦C for
5min. After a centrifugation (15,000 g for 20min at 4◦C),
the supernatants were discarded and 10% of the final volume
of ice-cold (−20◦C) tetrahydrofuran (BioBasic Inc., Markham,
Ontario, Canada) was again added, vortexed until complete
dissolution of the pellets and kept at −20◦C for 5min. After
centrifugation (15,000 g for 20min at 4◦C), the supernatants were
discarded and the pellets air-dried in a chemical hood for 30min,
dissolved in 210 µl of IEF buffer (pH 8.5), vortexed, centrifuged
(15,000 g for 10min at room temperature), and kept at −80◦C
until use.
Protein Conjugation
The proteins were conjugated with fluorescent cyanine dyes
(CyDye) and resolved by SDS-PAGE and 2D-DIGE according
to standard protocols. The CyDyes were synthesized by the
Sherbrooke Molecular Imaging Center based on a protocol by
Jung et al. (Jung et al., 2012). Briefly, the internal standard was
a mix of equivalent fractions of all the samples used in this study,
at a concentration higher than 25 µg, and conjugated with the
CyDye Fluor Cy2 dye. The different CyDyes were diluted to
a concentration of 400 pmol/µL in dimethylformamide (DMF;
BioBasic Inc., Markham, Ontario, Canada). The samples and
internal standards were adjusted to a pH of 8.5 with 2M NaOH
and conjugated as follow: 30µg of protein at 1µg/µL weremixed
with 1 µl of each CyDye (400 pmol/µl), vortexed, centrifuged
(12,000 g for 30 s at room temperature), and kept on ice for
30min in the dark. The reaction was stopped with 1 µl of 10mM
L-lysine (BioBasic Inc., Markham, Ontario, Canada), vortexed,
centrifuged (12,000 g for 30 s at room temperature), incubated on
ice for 10min, and immediately used or kept at −80◦C up to 3
months in the dark.
Electrophoresis
1D Electrophoresis
Gel electrophoresis of the conjugated proteins was performed
on a 4% stacking gel and 14% acrylamide/bisacrylamide (37.5:1)
resolving gel. Gels were 1.5mm thick and casted following a
specific protocol (Table 2). The migration was done using the
Mini-PROTEAN R© system (Biorad, Hercules, CA, USA) and
performed at a constant rate of 60mA, 2 h in 1X running buffer
(Table 2). Gel readings were done using a Typhoon Trio+ (GE
Healthcare, Little Chalfont, Buckinghamshire, United Kingdom).
The detection of CyDyes 3 and 5 was done at the optimal
photomultiplier voltage (PMT) for each one of them, for each gel
analyzed.
2D Electrophoresis
The different CyDyes mixes were pooled together. Ninety
microliters of the CyDye mix was added to 90 µl of a reduction
solution [7M urea (BioBasic Inc., Markham, Ontario, Canada),
2M thiourea (GE Healthcare, Little Chalfont, Buckinghamshire,
United Kingdom), 4% (w/v) CHAPS (BioBasic Inc., Markham,
Ontario, Canada), 0.5% (v/v) IPG (GE Healthcare, Little
Chalfont, Buckinghamshire, United Kingdom), 1mM
dithiothreitol (GE Healthcare, Little Chalfont, Buckinghamshire,
United Kingdom), 0.05% (v/v) bromophenol blue (Sigma,
Oakville, QC, Canada)], vortexed and incubated for 15min on
ice in the dark. The sample was centrifuged (21,000 g for 30 s at
room temperature) and the supernatant collected. The dyes were
randomly conjugated to the different protein samples.
The first dimension of the 2D electrophoresis, the isoelectric
focusing, was done on Immobiline DryStrip pH 3-11 NL, 24 cm
(GE Healthcare, Little Chalfont, Buckinghamshire, United
Kingdom) strips. They were rehydrated at room temperature
overnight with 450 µl of a mix of the remaining reduced
supernatant and rehydration solution [7M urea (BioBasic Inc.,
Markham, Ontario, Canada), 2M thiourea (GE Healthcare,
Little Chalfont, Buckinghamshire, United Kingdom), 4%
CHAPS (BioBasic Inc., Markham, Ontario, Canada), 0.5%
IPG (GE Healthcare, Little Chalfont, Buckinghamshire, United
Kingdom), 1.2% DeStreak rehydration solution (GE Healthcare,
Little Chalfont, Buckinghamshire, United Kingdom), 0.05%
bromophenol blue (Sigma, Oakville, QC, Canada)]. Migration
of the strips was done with the Ettan IPGphor 3 IEF system (GE
Healthcare, Little Chalfont, Buckinghamshire, United Kingdom)
following a specific protocol (Table 3). The strips were covered
with Plus One DryStrip cover fluid (GE Healthcare, Little
Chalfont, Buckinghamshire, United Kingdom) during the entire
migration and kept at−80◦C until use.
The second dimension of the 2D electrophoresis was done on
10–18% gradient polyacrylamide gels. The gels (26× 20 cm) were
casted with the DALTsix gel caster and the DALTsix gradient
maker (GEHealthcare, Little Chalfont, Buckinghamshire, United
Kingdom). The gels were cast following a specific recipe (Table 2)
combining light and heavy acrylamide solutions, in order to
generate a linear gradient between the two concentrations. The
light gel represents the solution with the lowest percentage
of total acrylamide (9.7%) while the heavy gel represents
the solution with the highest (maximum) percentage of total
acrylamide (17.8%). The gels were covered with 30% isopropyl
alcohol (Laboratoire MAT, Québec, Québec, Canada) and
polymerized for 3 h. The gels were then washed with apyrogenic
water, covered with a conservation buffer (Table 2) and kept
polymerizing for another 2 h.
The strips were thawed at room temperature and washed
for 20min under agitation in a DTT solution (Table 2). A
second 20minwash under agitation in an iodoacetamide solution
(Table 2) was done and the strips were added on top of the gels.
To maintain them in place, an overlays solution was added over
the strips (Table 2).
Themigrationwas done using the EttanDALTsix large vertical
system and performed at a constant rate of 0.5 W/gel for 1 h and
then over night at a constant rate of 1.25 W/gel in 1X running
buffer (Table 2). The whole system was kept at 20◦C with a
water-cooling system. Gels readings were done using a Typhoon
Trio+ (GEHealthcare, Little Chalfont, Buckinghamshire, United
Kingdom) as described above.
Visualization and Quantification of the
In-Gel Fluorescent Signals
CyDye-labeled gels were visualized using a Typhoon Trio Plus
laser scanner (GE Healthcare). Excitation and emission
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TABLE 3 | Detailed migration protocol for the 2D gel electrophoresis.
U (V) Time or Vh µA (I/strip) Temperature (◦C)
Step 1 500 500 75 20
Step 2 1000 800 75 20
Step 3 10,000 16,500 75 20
Step 4 10,000 32,200 75 20
wavelengths were chosen according to manufacturer’s
recommendations (488, 532, and 633 nm laser beams; 520, 580,
and 670 nm emission filters). Quantification of the fluorescent
signal was done using ImageJ software. The average pixel
saturation of the fluorescent signal from the Typhoon Image was
calculated and normalized for background fluorescence.
RESULTS
Comparison of Protein Extraction Methods
and the Effect of the Confluence Level and
Collection Time on the Protein Recovery
Yield
Repeated experiments, using fibroblasts collected from
two different neuronal pathologies (SALS/FALS and
neurofibromatosis) and controls revealed that the TCA-
DOC protein precipitation method was consistently superior to
the TCA-NLS-THF method to recover proteins (Figure 1). A
statistically significant difference between the two used protein
precipitation methods was revealed by a grouped analysis. A
2-way ANOVA followed by a Bonferroni post-hoc test with
a significance level of 0.05 was done using PRISM software
(GraphPad Software, Inc., San Diego). The error bar represents
the standard deviation. The TCA-DOC protein precipitation
method was consistently giving higher recovery yield when
compared to the TCA-NLS-THF method for each tested
condition (Figure 1). No significant differences were observed
in the recovered amount of secreted proteins between ALS
(SALS/FALS), NF1, and controls fibroblasts. We then tested
the influence of the confluence level as well as the collection
time (24 and 48 h at 40 or 95% of confluence) on the total
amount of secreted proteins recovered from each fibroblast
conditioned-media. The 48 h post-confluency culture condition
for both protein precipitation methods was proven to give the
better recovery yield (Figure 1). However, the higher recovery
yield was consistently obtained after a 48 h induction at 95%
of cell confluence with the TCA-DOC (1045.2 µg/ml) protein
precipitation method compared to the TCA-NLS-THF method
(713.9 µg/ml).
Effect of Cyanine Dye Conjugation on the
Recovered Protein
In order to determine if any of the protein precipitation methods
interfered with cyanine dye conjugation, we performed a one
dimension SDS-PAGE gel of secreted proteins precipitated from
fibroblast conditioned-medium and conjugated with different
commonly used CyDyes. As illustrated in Figure 2, both the
FIGURE 1 | Protein recovery yield in function of precipitation methods,
collection times, and confluence levels measured by the Bradford
assay. The yield of protein recovered following the two tested protein
precipitation methods (TCA-DOC and TCA-NLS-THF) and four different culture
conditions was measured by the Bradford assay. The amount of recovered
protein for all the tested conditions is given in µg/ml of
conditioned-supernatant. The TCA-DOC method consistently gave better
recovery yields independent of the induction conditions that were used.
***Corresponds to a P-value of <0.0001.
TCA-DOC and TCA-NLS-THF methods have no significant
effect on the conjugation with the CyDyes (3 and 5; Figure 2).
A 2-way ANOVA followed by a Bonferroni post-hoc test with
a significance level of 0.05 was done using PRISM software
(GraphPad Software, Inc., San Diego). The error bar represents
the standard deviation. The TCA-DOC method was therefore
selected for downstream 2D-DIGE proteomic studies since it
gives the higher and significant (P < 0.0001) recovery yield for
all the induction conditions tested.
Visualization of Whole Secreted Protein
Resolved with 2D-DIGE
A pool of precipitated proteins collected from all the samples
tested in this study, using the TCA-DOC method 48 h post-
confluence and induction, were conjugated with each CyDyes
(2, 3, and 5) and resolved with 2D-DIGE. The results show
that each CyDyes bind at the same effectiveness to the proteins,
giving an equal number of detected spots (502) for each
of the conjugation (Figure 3) indicating that the choice of
a specific CyDye does not affect or interfere with protein
detection. Conjugation of the samples for each tested conditions
was done in a randomized fashion between the two CyDyes
used in the study (Cy3 and Cy5). The conjugated proteins
mixture, precipitated from fibroblast conditioned-medium for
two different conditions, was subjected to isoelectric focusing
followed by a 10–18% SDS-PAGE gradient migration in the 2nd
dimension. To determine the number of spots detected, the Delta
2D analysis software V4.2 (Decodon, Greifswald, Germany) was
used. A data pool, comprised of all the gels and the CyDyes, was
created. Quantification of the number of spots detected between
different induction conditions and precipitation methods (TCA-
DOC post-confluence, 24 h of incubation/TCA-DOC, post-
confluence, 48 h of incubation/TCA-NLS-THF, post-confluence,
48 h of incubation) was also assessed. In line with our previous
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FIGURE 2 | One dimension SDS-PAGE gel of secreted proteins
precipitated from fibroblast conditioned-medium and conjugated with
CyDyes. (A) Conjugation of CyDyes 3 and 5 to TCA-DOC and TCA-NLS-THF
precipitated proteins. A 14% acrylamide/bisacrylamide (37.5:1) gel was used
to resolve the CyDye conjugated supernatant protein. An internal standard
was produced by conjugating protein from the TCA-DOC (Post-48 h) with both
Cy3 (green) and Cy5 (red) dyes. One fibroblast cell line per tested condition for
each of the studied pathology and control was tested and loaded in the gels in
this order: pre-confluence/24 h, post-confluence/48 h, pre-confluence/48 h,
post-confluence/48 h. Equal amount of proteins was loaded in all the gels. (B)
Quantification of the fluorescent signal, detected with our laser-scanner
Typhoon device, was done using ImageJ software. No statistical differences
were noted for each of the tested condition, indicating that any of the protein
precipitation method used in this study did not interfere with the CyDye
conjugation.
results showing that the TCA-DOC 48 h post-confluency was
given better protein recovery yield, more spots were also detected
using this method when compared to the two other conditions
tested (Figure 4).
DISCUSSION
The proteins secreted by a particular type of cell, the secretome,
play important roles in the regulation of many physiological
processes via paracrine/autocrine mechanisms, and they are
of increasing interest as potential biomarkers and therapeutic
targets in diseases (Pocsfalvi et al., 2011). The proteins released
by cells into conditioned media in vitro have been studied to
better understand pathological conditions and mechanisms in
vivo (Pocsfalvi et al., 2011; Ribeiro et al., 2011). However, the
secretome analysis still faces some problem mainly related to cell
preparation, protein extraction, enrichment, and conjugation.
To facilitate ongoing research involving secreted proteins, we
revisited cell culture protocols and whole secreted protein
enrichment. We identified the optimal fibroblast cells culture
protocol, secreted protein collection, as well as precipitation
method for the subsequent secretomic screening experiments.
The maximum recovery yield was obtained when collecting the
conditioned supernatants 48 h after induction when fibroblasts
were at 95% of confluence with the TCA-DOC precipitation
method. Washing the cells three times with PBS before serum
deprivation ruled out possible contaminants present in the
bovine serum (Rogers et al., 2014). It cannot be excluded however
that some intracellular proteins, released in the medium by
cellular lysis, might be present in the collected supernatants.
Nonetheless, since the serum-deprived protocol used to extract
proteins was the same for all tested conditions, it is unlikely
that the presence of lysis-derived contaminants would interfere
with the analysis and give false-positive results. Moreover, it
has been previously shown that the removal of bovine protein,
especially when using PBS, seems not to compromise the number
of living cells and to minimize the effects on cell lysis and
viability (Rogers et al., 2014). A comparative approach between
the conditioned-medium and cytosolic extract should however
be performed in order to normalize the results for the presence
of minimized lysis-derived contaminants. The concept of DIGE
was originally developed by Unlü and colleagues (Unlü et al.,
1997). This technique allows higher reproducibility and provides
information about more subtle changes in protein expression
than conventional 2D electrophoresis as three different sample
types can be run on the same gel and be directly compared to
one another, one being the internal standard (i.e., a pool of all
the samples of the experiment). This technique, relying on pre-
electrophoretic labeling of samples with one of three spectrally
resolvable fluorescent cyanine dyes (Cy2, Cy3, and Cy5), also
allows multiplexing of samples into the same gel, and has
become the method of choice over the last years for comparative
proteomic profiling in a cost-effective manner. With the different
2-D gel image analysis software available commercially, spot
detection as well as statistical analysis, proteome maps and spot
picking, for mass spectrometry (MS) analysis, can easily be done.
Table 4 presents a list of available software. Therefore, we have
identified the optimal technical parameters that shall be used in
the subsequent 2D fibroblast secretome profiling experiments.
According to our results, we therefore propose that protein
precipitation should be performed by TCA-DOC precipitation
method after 48 h at 95% of confluence in a serum-deprived
culture medium.
Comparative proteomic profiling is a relevant approach to
biomarker discovery and is becoming extensively utilized in
secretome analysis. Mainly, two prominent sources of secreted
proteins have been utilized in secretomic studies: cell line
supernatants derived from patients and proximal biological
fluids (blood, sera, cerebral spinal fluid, etc.). The availability
of skin fibroblasts is particularly advantageous for research
Frontiers in Cellular Neuroscience | www.frontiersin.org 7 March 2016 | Volume 10 | Article 70
Paré et al. Secreted Protein Recovery for Secretomic Analysis
FIGURE 3 | Visualization of whole secreted protein and quantification of the protein spots resolved with 2D-DIGE at the optimal induction condition.
Conjugation of each CyDye, Cy2 (A), Cy3 (B), and Cy5 (C), to precipitated proteins extracted from fibroblast conditioned-medium via the TCA-DOC method and
resolved by 2D-DIGE is shown. Please note that all technical replicates (disease and control) obtained for the 48 h post-confluence induction condition were pooled
together prior CyDye conjugation and loaded on gel. (D) Represents a fusion image of the three different CyDyes. Each individual spot is circled. The number of
detected spots (502) is indicated at the far right. Equal number of spots is detected for each of the tested CyDyes indicating that each of the specific tested CyDyes
bond with the same effectiveness and therefore that the conjugation efficiency is independent of the CyDye fluors.
involving neurological diseases, since it is difficult to obtain
affected tissues from living patients. The main function of
fibroblasts is to maintain the structural integrity of connective
tissues by continuously secreting precursors of the extracellular
matrix. Fibroblasts are readily cultured in research laboratories
and incorporation of fibroblasts into tissue-engineered skin
substitutes has produced encouraging results in the treatment
of severely burned patients, symptomatic pain relief, more
rapid healing of acute, chronic wounds, and even to model
different diseases such as ALS and psoriasis (Auger et al.,
1998, 2009; Moulin et al., 2000; Auxenfans et al., 2009; Jean
et al., 2009; Paré et al., 2015). As a matter of fact, this novel
tissue-engineered skin model derived from both sporadic
and familial ALS patients was reported to be the first to
present cytoplasmic TDP-43 accumulation in cells outside
of the nervous system. Furthermore, generation of human
induced pluripotent stem cells (iPSCs) from fibroblast cells
provides a new method to elucidate the molecular basis of
human diseases and a novel approach to disease modeling
and drug discovery (Takahashi et al., 2007; Yu et al., 2007).
Actually, an increasing number of studies have employed
disease-specific human iPSCs to model neurological diseases,
including Parkinson’s disease, Autism spectrum disorders,
Friedreich’s Ataxia, spinal muscular atrophy, ALS, Angelman
syndrome and Prader-Willi syndrome, and only few of them
have demonstrated disease-specific phenotypes (Dimos et al.,
2008; Park et al., 2008; Ebert et al., 2009; Soldner et al., 2009;
Chamberlain et al., 2010; Ku et al., 2010; Marchetto et al.,
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FIGURE 4 | Visualization and quantification of the protein spots of different tested induction conditions and precipitation methods. Proteins were
conjugated with the different CyDyes after extraction with the TCA-DOC, 24 h, post-confluence (Cy2) (A), TCA-NLS-THF, 48 h, post-confluence (Cy3) (B) and
TCA-DOC, 48 h post-confluence (Cy5) (C) induction conditions and precipitation methods and resolved by 2D-DIGE from one control cell line. Each individual spot is
circled and was automatically quantified by the software (far right). Note that the TCA-DOC 48h post-confluence induction condition, which was also consistently
given better protein recovery yield, gave the highest number of protein spots.
2010; Nguyen et al., 2011; Ryan et al., 2013; Velasco et al.,
2014). The potential of iPSCs technology is enormous, but
major obstacles to iPSC studies for late-onset neurodegenerative
diseases remains. Their production is still very expensive
and time consuming. iPSC also show genetic and epigenetic
abnormalities after time in culture, sometimes even showing
cancer-related mutations (Gore et al., 2011; Bhartiya et al.,
2013). This present study can overcome these mutations-related
problems since the skin fibroblasts are used without any
genetic modifications. They are also easier to work with than
iPSC-derived neurons since the culture medium needed is less
expensive and doesn’t need to be supplemented of various
chemical and biological compounds such as nerve growth
factors. The identical germ layer origin of both the skin and
neural tissue leads us to think that skin can also be used to
study neurodegenerative diseases. For instance, cytoplasmic
accumulation of TDP-43, a pathological signature of ALS and
ALS/FTD, was observed in the skin of ALS patients and in
ALS-derived tissue engineered skins (Paré et al., 2015). Thus,
fibroblast cells, able to secrete extracellular matrix molecules,
as the matrix metalloproteinases (MMPs), which were shown
to be associated with neural morphogenesis as well as being
important in the synaptic remodeling, on both the structural
TABLE 4 | Available 2D gel analysis software and spot quantification.
Company Software
Bio-Rad, Hercules, CA, USA PDQuest-2D
DECODON, Greifswald, Germany Delta2D
GE Healthcare, Little Chalfont,
Buckinghamshire, United Kingdom
DeCyder 2D/Image Master 2D
Platinum
Genbio, Geneva, Switzerland Melanie
Ludesi, http://www.ludesi.com Redfin
Syngene, Frederick, MD, USA Dymension
Totallab, Newcastle upon Tyne, United
Kingdom
SameSpots
and functional levels (McFarlane et al., 2003; Rivera et al., 2010;
Huntley, 2012), could be of major importance in understanding
pathophysiological mechanisms of neurodegenerative
diseases.
CONCLUSION
Comparative proteomic profiling of patient-derived fibroblasts
to elucidate the pathogenesis of rare diseases, especially
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neurological disorders, presents an attractive alternative to
neural tissue biopsies from living patients that are of limited
access. These new techniques will hopefully help researchers and
clinicians to better understand these yet untreatable diseases.
Conceivably, the proposed approach based on the study of
patient-derived skin fibroblasts to facilitate the identification of
biomarkers for early diagnosis or to monitor disease progression
becomes highly attractive and of high importance in clinical
neurology. A comprehensive survey of patient-derived whole
secreted proteins in fibroblast-conditioned media will certainly
lead to more translational research to facilitate the identification
of specific disease biomarkers and new molecular targets for
therapy or molecular signatures to improve early diagnosis, to
find a cure or to slow down the course of this yet untreatable
diseases.
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